Cannula Market Size was valued at USD 187.00 Billion in 2023. The Global Cannula industry is projected to grow from USD 200.00 Billion in 2024 to USD 298.00 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.10% during the forecast period (2024 - 2032).
A cannula is a small hollow tube with a sharpened and retractable inner core that is inserted into a vein, artery, or body cavity to deliver medication and remove fluids.
Cannulae are available for a range of procedures. During heart surgery, for example, an intravenous cannula is used to achieve cardiopulmonary bypass. A nasal cannula is used to supply oxygen by placing the plastic tubing behind the nose. It's also commonly used for filler injections because it's less painful, reduces the danger of bleeding and bruising, and has more flexibility than hypodermic needles. It is frequently utilized in hospitals, ambulatory surgery centers (ASCs), blood banks, laboratories, and pathology laboratories all over the world due to its many qualities.
The growing number of surgeries, innovations in healthcare facilities, more investment in research & development, a large patient pool, and rising government funding are the major factors driving this market. A primary driver of this business is the expanding usage of minimally invasive surgery (MIS) therapies.
In July 2022, B. Braun Medical Inc., a prominent player in infusion therapy, unveiled its latest product, the Introcan Safety 2 IV Catheter, with a unique one-time blood control mechanism. The Introcan Safety 2 IV Catheter, developed by B. Braun, aims to enhance the safety of IV access for healthcare professionals by minimizing the likelihood of needlestick injuries and potential blood exposure. The establishment of intravenous (IV) access is a crucial component of infusion therapy, and this invasive technique remains linked to possible hazards for healthcare providers.
Clinicians confront a significant risk of needlestick injuries in their regular practice. According to the CDC, there are around 385,000 incidents of sharps injuries annually, with more than 30% of these resulting from hollow-bore needles, such as those employed in peripheral IV catheters (PIVCs).
Research indicates that passive, fully automated safety systems exhibit double the effectiveness of a semi-automatic 'push-button' safety shield and three times the effectiveness of a manually sliding barrier. The Introcan Safety 2 provides clinicians with a fully automated passive safety mechanism, ensuring their protection. Healthcare personnel have concerns about both needlestick injuries and mucocutaneous blood exposure while initiating an IV. Indeed, the majority of nurses expressed apprehension regarding blood exposure, both in terms of their personal safety and the safety of their patients.
In certain international markets, Shockwave Medical has unveiled its new coronary intravascular lithotripsy (IVL) catheter in May 2023. The Shockwave C²⁺ IVL catheter is designed for the management of highly calcified coronary artery disease. The commercial availability of Shockwave C²⁺ for the treatment of de novo coronary artery disease is currently accessible in Europe and certain other regions. It is purported to provide a 50% increase in the number of pulses per catheter compared to Shockwave C².
Additionally, it is designed to effectively treat longer calcified lesions, as well as complex eccentric and nodular calcium formations. Shockwave C²⁺ retains the user-friendly catheter design and ease of use that have been crucial to the success of Shockwave IVL. It also includes enhancements that will improve procedural efficiency and optimize the treatment of complex morphologies.
The Cannula market has been segmented into product, material, application and end user.
The market, on the basis of product, has been segmented into cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas and others.
The market, by material, has been segmented into plastic (PVC), silicone and metal (stainless steel).
The market, by application, has been segmented into cardiovascular surgery, oxygen therapy, general surgery, plastic/cosmetic surgery, orthopaedic surgery and others.
The market, by end user, has been segmented into hospitals, ambulatory surgical centers and others. The hospitals segment is anticipated to hold the largest market share owing to increase in hospitalizations and large number of surgeries in hospitals. The ambulatory surgical centers are expected to grow at the highest CAGR owing to the increasing demand for modern healthcare facilities.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Cannula Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Cannula market in the Middle East & Africa has been segmented into the Middle East and Africa.
Some of the key players in the Cannula market are
Regional Market Summary
Geographically, the Americas is anticipated to dominate the Cannula market owing to rising healthcare expenditure, increase in number of surgeries and developing healthcare infrastructure. According to Centers Medicare and Medicaid Services, National Healthcare Expenditure grew by 4.3% to USD 3.3 trillion in 2016 from the previous year. Europe is expected to hold the second largest position in the market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities. The Cannula Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for minimally invasive surgeries and rising healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health. The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.
Recent Development
Intended Audience:
| Report Attribute/Metric | Details |
| Market Size | 2032: USD 298.00 Billion |
| CAGR | 8.10% (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | product, material, application and end user |
| Geographies Covered | Americas, Europe, Asia-Pacific, and the Middle East & Africa |
| Key Vendors | Medtronic, Edwards Lifesciences Corporation, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Smith & Nephew, CONMED Corporation, Smiths Medical, Teleflex Incorporated, Boston Scientific Corporation, McKesson Medical-Surgical Inc., Harsoria Healthcare Pvt. Ltd., ISPG Inc., ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA), Denex International, BD and others |
| Key Market Opportunities | More investment in research & development and rising government funding |
| Key Market Drivers | Growing number of surgeries, innovations in healthcare facilities and a large patient pool |
Cannula Market Highlights:
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
